ETrials Worldwide, founded in 1999, is a leading player in the eClinical sector, offering a seamless, real-time eClinical experience for the healthcare, pharmaceutical, and biotechnology industries. Headquartered near Research Triangle Park, North Carolina, with regional sales offices across the U.S. and European operations based in Sittingbourne, Kent in the U.K., ETrials delivers an all-encompassing eClinical solution that has supported over 400 clinical studies across more than 50 countries.
The company provides specialized consulting services and aids pharmaceutical firms in transitioning from paper-based to electronic data processes. It offers top-tier software and services for nearly every aspect of clinical trial information management, review, and comparison. Pioneering an open, standards-based technology platform, ETrials' last investment of $5.00M in Series A was made on 14 January 2004, with participation from Newlight Management, Prodea, and InfoLogix.
Through the integration of advanced technology with comprehensive services, ETrials ensures a systematic approach to conducting electronic trials, resulting in faster trial initiation, expedited data collection, and real-time availability of results. Importantly, the data seamlessly integrates with other trial processes, enabling better real-time decision-making across the eClinical platform. With its impressive track record and innovative approach, ETrials Worldwide is well-positioned to continue leading the way in the eClinical space.
